Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Drug Infusion Systems Market from 2024 to 2025?

The market size for drug infusion systems has seen significant expansion in the past few years. The market, valued at $13.42 billion in 2024, is predicted to reach $14.34 billion in 2025, showing a compound annual growth rate (CAGR) of 6.9%. The historic growth of this market is linked to several key factors, including the transition to electronic infusion devices, a rise in chronic diseases, progress in patient care strategies, the adoption of home-based infusion treatments, and the growth of ambulatory care settings.

What Is the Projected Market Size of the Drug Infusion Systems Market?

The market for drug infusion systems is anticipated to experience robust growth in the upcoming years. The market is projected to surge to “$20.46 billion by 2029, boasting a compound annual growth rate (CAGR) of 9.3%. The anticipated growth during this period is mainly due to a shift towards disposable systems, an increasing incidence of chronic illnesses, the development of ambulatory care facilities, customised medication and adaptive dosing, along with a growing demand for in-home care. Key trends expected during this forecast period involve wireless connectivity, remote monitoring, integration into electronic health records (EHR), smart pump technology, personalised and adaptive dosing, and less invasive infusion methods.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

Who are the Major Competitors in the Drug Infusion Systems Market Outlook?

Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

What Is Fueling Growth in the Drug Infusion Systems Market?

The escalation in the occurrence of chronic diseases is anticipated to stimulate the expansion of the drug infusion system market. Conditions such as cancer, diabetes, cardiovascular disease, and autoimmune disorders often necessitate enduring or constant infusion therapy. Drug infusion systems provide a secure, efficient, and effective method to dispense medication to patients with these ailments. The prevalence has been escalating at a faster pace in low- and middle-income nations compared to wealthier countries. Diabetes is a primary cause of renal failure, heart attacks, strokes, blindness, and lower limb amputation. For instance, in February 2024, as per the findings published by Centers for Disease Control and Prevention (CDC), a US-based entity, they reported an increasing population in America is grappling with multiple chronic conditions, with 42% experiencing two or more and 12% enduring five or more. Hence, the growth of the drug infusion system market is driven by the surge in demand due to the increasing occurrence of chronic diseases.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

Which Drug Infusion Systems Market Segments Are Growing the Fastest?

The drug infusion systems market covered in this report is segmented –

1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

Subsegments:

1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

Which Industry Trends Are Shaping the Future of the Drug Infusion Systems Market?

Prominent firms in the drug infusion systems market are innovating and introducing advanced technology like cloud-based infusion management systems to optimize patient care, increase accuracy, and simplify the management process of infusion treatments. These are digital platforms hosted on the cloud that aid in observance, administration, and tracing of medication infusions. To illustrate, Eitan Medical, a prominent leader in advanced infusion therapy and drug delivery based in the US, introduced Eitan Insights in June 2023 – a state-of-the-art cloud-based infusion management system fashioned to cater to the specific requirements of home and specialty infusions. This system is built to furnish healthcare workers with real-time data and analytics, empowering them to supervise patients remotely and make necessary adjustments to treatment plans. Eitan Insights effectively enhances drug safety by decreasing the likelihood of mistakes and upholding adherence to prescribed procedures.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

Which Countries Are Leading the Drug Infusion Systems Market?

North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10703

This Report Delivers Insight On:

1. How big is the drug infusion systems market, and how is it changing globally?

2. Who are the major companies in the drug infusion systems market, and how are they performing?

3. What are the key opportunities and risks in the drug infusion systems market right now?

4. Which products or customer segments are growing the most in the drug infusion systems market?

5. What factors are helping or slowing down the growth of the drug infusion systems market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model